Literature DB >> 26277071

Maternal immunization in Argentina: A storyline from the prospective of a middle income country.

C Vizzotti1, S Neyro2, N Katz1, M V Juárez1, M E Perez Carrega1, A Aquino1, F Kaski Fullone3.   

Abstract

The importance of vaccination during pregnancy lies not only in directly protecting vaccinated women, but also by indirectly protecting small infants during the first few months of life. Vaccination against the flu and whooping cough is a priority within the comprehensive care strategy for pregnant women and small infants in Argentina, in the context of transitioning from child vaccination to family vaccination. In 2011, the flu vaccine was included in the National Immunization Schedule (NIS) as mandatory and free of charge, with the aim of decreasing complications and death due to influenza in the at-risk population in Argentina. The national vaccination coverage attained in pregnant women in the past 4 years (2011-2014) has been satisfactory; 88% coverage was attained in the year this program was introduced to the schedule. In the following years, coverage was maintained at greater than 95%. In February 2012, Argentina became the first country in Latin America to have universal vaccination strategy for pregnant women against whooping cough. This recommendation was implemented throughout the country by vaccination with the diphtheria toxoid, tetanus toxoid, and acellular pertussis (Tdap) vaccine starting at 20 weeks of pregnancy, with the aim of decreasing morbimortality due to whooping cough in infants under 6 months of age. The vaccine was incorporated into the NIS in 2014. More than 1,200,000 doses were applied in this period. Both vaccines showed a suitable safety profile and no serious events were reported. Argentina is an example of a middle-income country that has been able to implement a successful strategy for primary prevention through vaccines, making it a health policy.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Flu; Health policies; Pregnancy; Tdap; Vaccination; Vaccination coverage; Whooping cough

Mesh:

Substances:

Year:  2015        PMID: 26277071     DOI: 10.1016/j.vaccine.2015.07.109

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women.

Authors:  Eleonora Agricola; Francesco Gesualdo; Lia Alimenti; Elisabetta Pandolfi; Emanuela Carloni; Angelo D'Ambrosio; Luisa Russo; Ilaria Campagna; Beatrice Ferretti; Alberto E Tozzi
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

2.  Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.

Authors:  Ousseny Zerbo; Bruce Fireman; Nicola P Klein
Journal:  Expert Rev Vaccines       Date:  2021-10-08       Impact factor: 5.683

Review 3.  Immunization During Pregnancy: Impact on the Infant.

Authors:  Kirsten P Perrett; Terry M Nolan
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

4.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

5.  Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age.

Authors:  Viviana Romanin; Anna M Acosta; Maria Del Valle Juarez; Elizabeth Briere; Stella Maris Sanchez; Beatriz Lopez Cordoba; Maria Eugenia Sevilla; Maria Florencia Lucion; Anahi Urrutia; Sandra Sagradini; Tami H Skoff; Carla Vizzotti
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

6.  Pertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation.

Authors:  G Fabricius; P Martin Aispuro; P Bergero; D Bottero; M Gabrielli; D Hozbor
Journal:  Epidemiol Infect       Date:  2018-04-15       Impact factor: 4.434

7.  What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis.

Authors:  Louise B Russell; Sri Ram Pentakota; Cristiana Maria Toscano; Ben Cosgriff; Anushua Sinha
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

8.  Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction.

Authors:  Gayatri Amirthalingam; Helen Campbell; Sonia Ribeiro; Norman K Fry; Mary Ramsay; Elizabeth Miller; Nick Andrews
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

Review 9.  Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.

Authors:  Ajoke Sobanjo-Ter Meulen; Philippe Duclos; Peter McIntyre; Kristen D C Lewis; Pierre Van Damme; Katherine L O'Brien; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

Review 10.  Lessons learnt from the implementation of maternal immunization programs in England.

Authors:  G Amirthalingam; L Letley; H Campbell; D Green; J Yarwood; M Ramsay
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.